Organs-on-chips for large-scale drug screening
Hughes Lab
"This is truly a unique platform - we have recreated in a dish the key element common to all tissues, which is that they depend on blood vessels for their survival. This feature is missing in all previously described in vitro organ cultures," Hughes said.
Hughes' team was also able to establish a functional vascularized microtumor (VMT) within the 96-well plate system and demonstrated its potential for anti-cancer drug screening. Working with a panel of FDA-approved anti-cancer drugs and a human colon cancer, they found that the VMT platform could accurately identify drugs that target the tumor cells, the vessels that supply them, or both.
"This is a major breakthrough", continued Dr. Hughes, "For the first time we can identify in the same assay drugs that target both tumor cells and the vessels that feed them."
Original publication
Phan, Duc T. T. and Wang, Xiaolin and Craver, Brianna M. and Sobrino, Agua and Zhao, Da and Chen, Jerry C. and Lee, Lilian Y. N. and George, Steven C. and Lee, Abraham P. and Hughes, Christopher C. W.; "A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications"; Lab Chip; 2017
Original publication
Phan, Duc T. T. and Wang, Xiaolin and Craver, Brianna M. and Sobrino, Agua and Zhao, Da and Chen, Jerry C. and Lee, Lilian Y. N. and George, Steven C. and Lee, Abraham P. and Hughes, Christopher C. W.; "A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications"; Lab Chip; 2017
Topics
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.